CLINICAL_TRIALS
trial_result
· 2021-10-21
Clinical Trial Update: Losartan for the Treatment of Pediatric NAFLD [Phase 2]
Summary
Phase 2 trial investigating losartan for pediatric nonalcoholic fatty liver disease was terminated; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: NAFLD - Nonalcoholic Fatty Liver Disease | Phase 2 | Status: TERMINATED | Results posted: 2021-10-21